Feed mycotoxin detoxifiers market seen reaching $3.87 billion by 2035

The feed mycotoxin detoxifiers market is projected to rise from $2.52 billion in 2025 to $3.87 billion by 2035 as tougher food-safety rules, the phaseout of antibiotic growth promoters and climate-driven contamination boost demand. Binders still lead the market, but enzyme-based biotransformers are emerging as the fastest-growing opportunity.

Why it matters: - Feed mycotoxin detoxifiers help protect animal health, crop productivity and food safety across the global feed chain. - The market’s projected growth signals more spending on toxin control as contamination risks become harder to manage. - Stricter regulation and climate pressure are turning mycotoxin mitigation into a routine feed-cost item rather than a niche add-on.

What happened: - Market Research Future valued the global feed mycotoxin detoxifiers market at $2.52 billion in 2025. - The research firm projected the market will reach $3.87 billion by 2035. - The forecast implies a 4.38% compound annual growth rate through 2035. - The market research highlights were released Aug. 27, 2026, in New York.

The details: - Tighter limits on mycotoxins such as aflatoxin and deoxynivalenol are a major demand driver. - The European Commission’s revision of Directive 2002/32/EC lowered permissible aflatoxin B1 levels in compound feed to 5 µg/kg. - China’s GB 13078 standards require comprehensive mycotoxin testing on imported grains. - More than 45 countries have banned in-feed antibiotics, increasing the need for dedicated detoxification tools. - Climate change is pushing Fusarium species that produce DON farther north into Canada, Northern Europe and the Black Sea region. - Binders hold 71.5% of the market and remain the dominant sub-additive category. - Bentonite clays and yeast cell wall feed additives are among the common binder products. - Biotransformers are the fastest-growing sub-additive segment. - These enzyme-based products break down mycotoxins into non-toxic metabolites. - The European Union’s authorization of a fumonisin esterase is helping speed adoption of biotransformers. - Poultry accounts for 50.2% of end-user demand. - Broilers are especially vulnerable to aflatoxins, which makes poultry a core use case for detoxifiers. - Aquaculture is growing fast, with shrimp and salmon producers in Southeast Asia and Chile increasing feed toxin mitigation efforts. - Asia-Pacific leads the market with a 33.4% share. - North America is the fastest-growing region. - Europe holds a 28.5% market share. - Key companies in the market include BASF SE, Cargill, Kemin Industries, dsm-firmenich (BIOMIN) and Alltech.

Between the lines: - The market is shifting from broad toxin binding toward more targeted enzyme-based systems. - That shift reflects pressure to preserve nutrients, improve performance and address co-contamination from multiple toxins at once. - Rapid testing and AI-driven analytics are also making batch-by-batch dosing more practical, which could change how feed mills buy detoxifiers. - ESG requirements are pushing retailers and livestock supply chains to document mycotoxin monitoring alongside antibiotic-free sourcing.

What's next: - Enzyme-based biotransformation is likely to remain the main growth opportunity as approvals expand. - Digital surveillance and precision dosing could improve efficiency and lower inclusion costs for feed mills. - Sub-Saharan Africa and parts of South Asia offer long-term expansion potential as financing and micro-dosing models improve access. - Competition is expected to intensify around multi-component adsorbents that can handle several toxins at once. - Market Research Future offers a sample report and paid access to the full study through its website.